GBS Global’s Patent-Pending API
- Parkinson’s Disease
- Lewy Body Dementia
- Huntington’s Disease
- Dementia
- Alzheimer’s Disease
- Osteoarthritis
- Rheumatoid Arthritis
- Crohn’s disease
- Inflammatory Bowel
- Allergic Asthma
- COPD/Asthma
- Eczema
- Mast Cell Activation
- Urticarias
- Dermatitis
- Anaphylactic/ Sting
- Canine Mastocytosis
- Post Herpetic Pain
- Cardio Disease Prevention
- Hyperlipidemia
- Hypertension
- Cardiac Hypertrophy
- Chronic Pain
- Acute Pain
- Inflammatory Pain
- Neuropathic Pain
- Cardiac Hypertrophy
- Urinary Cystitus
- Hearing loss
- Chronic Wound
- Surgical Wound
- Diabetic Wound
- Hearing Loss
- Urinary Cysts
RX - Prescription Drug Programs
Major Markets
- Neurodegenerative Disorders = $85 Billion (US)
- i.e. Parkinson’s & Alzheimer’s Diseases
- Chronic/Neuropathic Pain = $650 Billion (US)
- i.e. Neuropathic Pain & HIV Neuropath
- Cardiovascular Disease = $316 Billion (US)
- i.e. Prevention & Treatment of Cardiac Hypertrophy
- Inflammatory Conditions = $200 Billion (US)
- i.e. Rheumatoid arthritis & Mast Cell Activation Syndrome
